Advanced Cell Technology touts positive trial results of stem cell therapy

04/26/2010 | Mass High Tech (Boston)

Advanced Cell Technology reported that its Stargardt's macular dystrophy treatment, which uses retinal pigment epithelium cells, did not cause any side effects in animal subjects. The biotech firm plans to launch human trials of the stem cell therapy in Oregon, New Jersey and Massachusetts.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX